AAV-AQP1

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameAAV-AQP1
Drug Alias NameA-00XAAV-AQP1AAV2-hAQP1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionAquaporin-1 gene transference
TargetsAquaporin-1
Therapy Area/IndicationsXerostomiaSjogren's SyndromeHead and Neck Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeiragtx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiragtx LtdMeiragtx LlcMeiragtx Uk Ii Ltd
Inactive CompaniesN/A
Active IndicationsXerostomiaSjogren's SyndromeHead and Neck Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A